Evaluation of vitamin D-binding protein and vitamin D metabolite loss in children on continuous ambulatory peritoneal dialysis.

[1]  B. Sörbo,et al.  Serum concentrations of 25-hydroxyvitamin D and vitamin D-binding protein in elderly people. Effects of institutionalization, protein-energy malnutrition and inflammation. , 2009, Acta medica Scandinavica.

[2]  S. Shany,et al.  Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients. , 1991, Kidney international.

[3]  R. Blomhoff,et al.  Uptake and degradation of vitamin D binding protein and vitamin D binding protein-actin complex in vivo in the rat. , 1990, The Biochemical journal.

[4]  H. Tanaka,et al.  Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets. , 1989, Bone and mineral.

[5]  J. Haddad,et al.  Vitamin D binding protein (Gc-globulin). , 1989, Endocrine reviews.

[6]  W. M. Lee,et al.  Alterations in Gc levels and complexing in septic shock. , 1989, Circulatory shock.

[7]  J. Delmez,et al.  Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. , 1989, The Journal of clinical investigation.

[8]  R. Bouillon,et al.  New Aspects of the Plasma Carrier Protein for 25‐Hydroxycholecalciferol in Vertebrates , 1988, Annals of the New York Academy of Sciences.

[9]  R. Kew,et al.  Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. , 1988, The Journal of clinical investigation.

[10]  S. Andreoli,et al.  Calcium carbonate is an effective phosphorus binder in children with chronic renal failure. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  J. Russell,et al.  Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene. , 1986, Endocrinology.

[12]  J. Haddad,et al.  Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. , 1986, The Journal of clinical endocrinology and metabolism.

[13]  J. Delmez,et al.  Continuous ambulatory peritoneal dialysis and bone. , 1986, Kidney international.

[14]  N. Cooke,et al.  Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. , 1985, The Journal of clinical investigation.

[15]  P. Siiteri,et al.  Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. , 1985, The Journal of clinical endocrinology and metabolism.

[16]  J. Haddad,et al.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. , 1984, The Journal of clinical investigation.

[17]  H. Kangarloo,et al.  Renal Osteodystrophy in Children Undergoing Continuous Ambulatory Peritoneal Dialysis , 1984, Pediatric Research.

[18]  J. Balfe,et al.  Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis. , 1983, The Journal of pediatrics.

[19]  T. Kobayashi,et al.  Variation of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 levels in human plasma obtained from 758 Japanese healthy subjects. , 1983, Journal of nutritional science and vitaminology.

[20]  M. Garabédian,et al.  Evaluation of 25-hydroxyvitamin D and vitamin D binding protein losses in thirteen children on continuous ambulatory peritoneal dialysis. , 1983, The International journal of pediatric nephrology.

[21]  P. G. Walsh,et al.  "Rocket" immunoelectrophoresis assay of vitamin D-binding protein (Gc globulin) in human serum. , 1982, Clinical chemistry.

[22]  J. Silver,et al.  Transport of vitamin D sterols in human plasma: effect of excess vitamin D, 25 hydroxyvitamin D and 1,25 dihydroxyvitamin D , 1979, European journal of clinical investigation.

[23]  B. Boucher,et al.  VITAMIN-D METABOLISM IN NEPHROTIC SYNDROME , 1977, The Lancet.

[24]  L. Cavalli-Sforza,et al.  Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Lawson,et al.  Competitive protein-binding assay for 25-hydroxycholecalciferol. , 1974, Clinical science and molecular medicine.

[26]  H. Yde.  WHEN TO EAT. , 1964, Lancet.

[27]  T. Huang,et al.  Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients. , 1990, American journal of nephrology.

[28]  J. Kanis,et al.  Intravenous calcitriol lowers serum calcium concentrations in uraemic patients with severe hyperparathyroidism and hypercalcaemia. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  L. Lind,et al.  Suppression of serum parathyroid hormone levels by intravenous alphacalcidol in uremic patients on maintenance hemodialysis. A pilot study. , 1988, Nephron.

[30]  B. Lindholm,et al.  Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). , 1988, Clinical nephrology.

[31]  G. Zilleruelo,et al.  Minerals and bone-modulating hormones in children on continuous ambulatory peritoneal dialysis. , 1985, Nephron.

[32]  Y. Seino,et al.  Competitive protein binding assay for plasma 25-hydroxycholecalciferol. , 1980, Methods in enzymology.

[33]  K. Kosaka,et al.  The effects of diseases of the liver on serum 25-hydroxyvitamin D and on the serum binding protein for vitamin D and its metabolites. , 1979, The Journal of laboratory and clinical medicine.

[34]  A. Hay,et al.  The plasma transport proteins of 25-hydroxycholecalciferol in fish, amphibians, reptiles and birds. , 1976, Comparative biochemistry and physiology. B, Comparative biochemistry.